Patent application number | Description | Published |
20080251636 | AIRCRAFT THAT COMPRISES A STRUCTURE THAT ENSURES THE STRUCTURAL AND ELECTRICAL FUNCTIONS - An aircraft includes a structure with structural elements ( | 10-16-2008 |
20100308165 | STRUCTURAL FRAME MADE OF A COMPOSITE MATERIAL AND AIRCRAFT FUSELAGE COMPRISING SUCH A FRAME - The invention relates to a structural frame made from a composite material. | 12-09-2010 |
20100330859 | METHOD OF CREATING COMPOSITE COMPONENTS WITH A PREFORM WITH HYBRID LAYUP - A method for manufacturing a thin structural component made of composite and intended to withstand, on the one hand, working loads and, on the other hand, accidental loadings. The method involves creating a dry fiber preform of the component that is to be manufactured, and impregnating the aforementioned perform with a matrix-forming resin by resin transfer. The perform is created by assembling at least one structural layer, a first surface reinforcing layer on a first face of the aforementioned structural layer, and a second surface reinforcing layer on a second face of the structural layer. A number of plies in the two surface reinforcing layers is first of all calculated so that the finished component will be able to withstand the accidental loadings, then a number of plies in the structural layer is calculated, with due consideration given to increases in structural strength contributed by the surface reinforcing layers so that the finished component will be able to withstand the working loads. | 12-30-2010 |
20110299993 | COMPOSITE STRUCTURAL MEMBER WITH PROGRESSIVE RIGIDITY - The invention relates to a composite structural member with fiber reinforcement and its application in the production of a wing box for aircraft. More specifically, it relates to a composite structural member ( | 12-08-2011 |
20130192433 | Method for disassembly of two elements welded by ultrasound and element able to be welded by ultrasound to another element to the implementation of said method - A method for disassembling two ultrasonically welded elements, one of the elements comprising, at a surface opposite the other element, an energy director that concentrates the heating during ultrasonic welding and forms a material junction between the two assembled elements after the ultrasonic welding. The method includes the steps of positioning a wire between the two assembled elements, so as to be secant to the energy director, said wire having suitable mechanical characteristics allowing it to cut the junction formed by the energy director and moving the wire between the two assembled elements so as to cut said junction. | 08-01-2013 |
20130206324 | Method for producing a central wing box - A method for producing a central wing box having an upper panel, a lower panel, a front spar and a rear spar, the upper edges of said spars approximately parallel to an axis Y being connected by the upper panel, and the lower edges of said spars approximately parallel to the axis Y being connected by the lower panel. The method includes producing at least one panel and at least one spar from composite material in one piece. | 08-15-2013 |
20130299636 | KEEL BEAM OF AN AIRCRAFT - A keel beam connected to a central wing box of an aircraft and ensuring the connection between a front structure and a rear structure of an aircraft is characterized in that it includes, on the one hand, a U-shaped body with a horizontal base and two solid lateral walls, and on the other hand, a cover which has a U shape oriented in the same manner as the body, with a base in the lower portion and curved edges, the ends of which are oriented upward so that each curved edge includes an outer surface flattened against and fixed to the inner surface of the lateral walls in order to define, with the body, a closed section, the cover including openings for accessing the inside of the keel beam. | 11-14-2013 |
Patent application number | Description | Published |
20090311315 | Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists - The invention relates to oral pharmaceutical forms with modified release of ARB, and to related treatments and delivery methods. | 12-17-2009 |
20100009005 | Novel acetysalicylic acid formulations - The invention relates to pharmaceutical compositions of acetylsalicylic acid-based microcapsules to selectively inhibit the COX in the portal vein and/or in the liver to reduce the production of thromboxane. Further, the pharmaceutical composition minimizes COX inhibition in the systemic circulation to optimize the inhibition of platelet aggregation. Certain embodiments also address methods of prevention and/or treatment of these diseases, using these oral compositions such as enhancing the safety of antithrombotic treatments. Other embodiments contemplate oral pharmaceutical compositions that combine acetylsalicylic acid with anti-platelet aggregation drugs, without inducing gastric side effects. | 01-14-2010 |
20100068291 | Oral Medicament Based on a Proton Pump Inhibitor - The invention relates to oral medicaments having a modified release of proton pump inhibitors (PPI's) that are, in particular, useful in preventing and treating gastrointestinal disorders. The aim of the invention is to provide a novel oral medicament based on PPI's ideally having all or some of the following characteristics: a) quickly providing relief to the patient by increasing the gastric pH after oral administration of the medicament; b) accelerating the recovery of patients while maintaining this increase in the gastric pH for as long as possible after oral administration of the medicament and, in particular, during the night; c) improving the observance of the treatment and the comfort of the patient by taking the medicament once daily. To this end, the microcapsules of the invention, preferably non-enteric, are constituted of PPI microparticles coated with ethyl cellulose, an ammonio methacrylate copolymer (Eudragit® RL 100), polyvinylpyrrolidone, castor oil and polyoxyethylenated hydrogenated castor oil ( | 03-18-2010 |
20100137456 | Polysaccharides functionalized by tryptophan derivatives - The present invention relates to novel polysaccharide derivatives, predominantly comprising glycosidic bonds of (1,4), (1,3) and/or (1,2) type, functionalized by at least one tryptophan derivative. It also relates to processes for the synthesis thereof, to their uses as pharmaceutical excipient and to the pharmaceutical compositions comprising them. | 06-03-2010 |
20110159088 | ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS - The field of the present invention is that of oral pharmaceutical forms of at least one active principle AP whose solubility varies greatly as a function of the gastric pH, and also treatments and administration methods relating thereto. | 06-30-2011 |
20130065826 | Injectable solution at pH 7 Comprising at least one basal insulin whose PI is between 5.8 and 8.5 - A composition in the form of an injectable aqueous solution, the pH of which is between 6.0 and 8.0, includes at least a basal insulin, the isoelectric point pI of which is between 5.8 and 8.5; and a dextran substituted by radicals carrying carboxylate charges and hydrophobic radicals. Single-dose formulations at a pH of between 7 and 7.8 includes a basal insulin whose isoelectric point is between 5.8 and 8.5 and a prandial insulin. | 03-14-2013 |
Patent application number | Description | Published |
20080234227 | Dextran functionalized by hydrophobic amino acids - The invention relates to a dextran functionalized by at least one hydrophobic alpha-amino acid radical, said alpha-amino acid being grafted or bonded to the dextran by a bonding arm and a functional group. A hydrophobic amino acid radical is understood as being the product of coupling between the amine of the amino acid and an acid carried by the bonding arm, said dextran being amphiphilic at neutral pH. In an embodiment, the hydrophobic amino acid is selected from tryptophan derivatives, such as tryptophan, tryptophanol, tryptophanamide, 2-indole ethyl-amine and their alkaline cation salts. The present invention relates also to a pharmaceutical composition comprising one of the dextrans according to the invention. | 09-25-2008 |
20080293635 | Angiogenic composition - The present invention relates to a amphiphilic polymer in the preparation of a therapeutic composition for promoting angiogenesis at its site of administration, comprising a complex between a polymer and a PDGF, wherein the polymer is amphiphilic. | 11-27-2008 |
20090221805 | Complex polymere amphiphile-PDGF - Physically and chemically stable, water-soluble, amphiphilic polymer-PDGF complex, characterized in that the amphiphilic polymers include a hydrophilic polymeric backbone functionalized with hydrophobic substituents and hydrophilic groups. | 09-03-2009 |
20110301086 | Complex polymere amphiphile-PDGF - Physically and chemically stable, water-soluble, amphiphilic polymer-PDGF complex, characterized in that the amphiphilic polymers include a hydrophilic polymeric backbone functionalized with hydrophobic substituents and hydrophilic groups. | 12-08-2011 |
20120041079 | DEXTRAN FUNCTIONALIZED BY HYDROPHOBIC AMINO ACIDS - Dextran of the following general formula I: | 02-16-2012 |
Patent application number | Description | Published |
20090305948 | Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications - The invention concerns novel materials based on biodegradable branched polyaminoacids particularly useful for transporting active principle(s). The invention also concerns novel pharmaceutical, cosmetic, dietetic or phytosanitary compositions based on polyaminoacids. The invention aims at providing a novel polymeric material, capable of being used for transporting active principle(s) and enabling all the required relevant specifications to be optimally satisfied: biocompatibility, biodegradability, easy ability to be combined with a large number of active principles or to solubilize same, and to release said active principles in vivo. This is achieved by the present invention which firstly concerns branched polyaminoacids comprising aspartic acid units and or glutamic acid units, and which bear hydrophobic groups including 8 to 30 carbon atoms. Said branched polyaminoacids are amphiphilic and are capable of being easily and economically transformed into particles for transporting active principles, said particles being themselves capable of forming stable aqueous colloidal suspensions. | 12-10-2009 |
20100034886 | Polyglutamic Acids Functionalised by Histidine Derivatives and Hydrophobic Groups and the Uses Thereof, in Particular for Therapeutic Purposes - The invention relates to novel biodegradable materials based on modified polyamino acids and suitable, in particular, for vectoring active substance(s) (AS). Said invention also relates to novel pharmaceutical, cosmetic, dietary or plant protective compositions which are based on said polyamino acids. | 02-11-2010 |
20100137456 | Polysaccharides functionalized by tryptophan derivatives - The present invention relates to novel polysaccharide derivatives, predominantly comprising glycosidic bonds of (1,4), (1,3) and/or (1,2) type, functionalized by at least one tryptophan derivative. It also relates to processes for the synthesis thereof, to their uses as pharmaceutical excipient and to the pharmaceutical compositions comprising them. | 06-03-2010 |
20110044930 | COPOLYHYDROXYALKYLGLUTAMINES FUNCTIONALISED WITH HYDROPHOBIC GROUPS, AND USES THEREOF, ESPECIALLY IN THERAPEUTICS - The invention relates to novel biodegradable materials which are based on modified polyamino acids and which can be used for the vectorisation of active principle(s) (AP). The invention also relates to novel pharmaceutical, cosmetic, dietary or phytosanitary compositions based on said polyamino acids. The aim of the invention is to provide a novel polymer raw material which can be used for the vectorisation of active principles and which can optimally fulfil all required specifications in said area, namely: biocompatibility, biodegradability and the ability to become easily associated with many active principles or to solubilise said principles and to release same in vivo. Said aim is achieved with novel copolyhydroxyalkylglutamines comprising glutamine units and optionally glutamate units and bearing hydrophobic groups containing between 8 and 30 carbon atoms. Said copolyhydroxyalkylglutamines are amphiphilic and can be easily and economically transformed into particles for the vectorisation of active principles, whereby said particles can form stable aqueous colloidal suspensions. | 02-24-2011 |
20120295833 | Polysaccharides having an adjustable degree of functionalization - An anionic polysaccharide comprising carboxylic acid functional groups of formula I: | 11-22-2012 |